GB9523959D0 - Materials and methods relating to the diagnosis and prophylactic and therapeutic treatment of cancer - Google Patents

Materials and methods relating to the diagnosis and prophylactic and therapeutic treatment of cancer

Info

Publication number
GB9523959D0
GB9523959D0 GBGB9523959.6A GB9523959A GB9523959D0 GB 9523959 D0 GB9523959 D0 GB 9523959D0 GB 9523959 A GB9523959 A GB 9523959A GB 9523959 D0 GB9523959 D0 GB 9523959D0
Authority
GB
United Kingdom
Prior art keywords
prophylactic
diagnosis
cancer
materials
therapeutic treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9523959.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cancer Research Campaign Technology Ltd
Original Assignee
Cancer Research Campaign Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Research Campaign Technology Ltd filed Critical Cancer Research Campaign Technology Ltd
Priority to GBGB9523959.6A priority Critical patent/GB9523959D0/en
Publication of GB9523959D0 publication Critical patent/GB9523959D0/en
Priority to DK96939218T priority patent/DK0858467T3/en
Priority to JP51952797A priority patent/JP2001507563A/en
Priority to US08/755,587 priority patent/US6045997A/en
Priority to GB9624453A priority patent/GB2307477B/en
Priority to ES96939218T priority patent/ES2217328T3/en
Priority to EP96939218A priority patent/EP0858467B1/en
Priority to PCT/GB1996/002904 priority patent/WO1997019110A1/en
Priority to CA002238010A priority patent/CA2238010A1/en
Priority to AU76350/96A priority patent/AU707636C/en
Priority to AT96939218T priority patent/ATE259378T1/en
Priority to DE69631540T priority patent/DE69631540T2/en
Pending legal-status Critical Current

Links

GBGB9523959.6A 1995-11-23 1995-11-23 Materials and methods relating to the diagnosis and prophylactic and therapeutic treatment of cancer Pending GB9523959D0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
GBGB9523959.6A GB9523959D0 (en) 1995-11-23 1995-11-23 Materials and methods relating to the diagnosis and prophylactic and therapeutic treatment of cancer
DE69631540T DE69631540T2 (en) 1995-11-23 1996-11-25 MATERIALS AND METHODS RELATING TO THE IDENTIFICATION AND SEQUENCING OF THE CANCER SUSCEPTIBILITY BRCA2 AND ITS APPLICATIONS
GB9624453A GB2307477B (en) 1995-11-23 1996-11-25 Materials and methods relating to the identification and sequencing of the BRCA2 cancer susceptibility gene and uses thereof
JP51952797A JP2001507563A (en) 1995-11-23 1996-11-25 Materials and methods for identification and sequencing of BRCA2 cancer susceptibility genes and uses thereof
US08/755,587 US6045997A (en) 1995-11-23 1996-11-25 Materials and methods relating to the identification and sequencing of the BRCA2 cancer susceptibility gene and uses thereof
DK96939218T DK0858467T3 (en) 1995-11-23 1996-11-25 Materials and Methods for the Identification and Sequencing of BRCA2 Cancer Sensitivity Gene and Their Uses
ES96939218T ES2217328T3 (en) 1995-11-23 1996-11-25 MATERIALS AND PROCEDURES RELATED TO THE IDENTIFICATION AND SEQUENCING OF THE SUSCEPTIBILITY GENE TO CANCER BRCA2 AND USES THEREOF.
EP96939218A EP0858467B1 (en) 1995-11-23 1996-11-25 Materials and methods relating to the identification and sequencing of the brca2 cancer susceptibility gene and uses thereof
PCT/GB1996/002904 WO1997019110A1 (en) 1995-11-23 1996-11-25 Materials and methods relating to the identification and sequencing of the brca2 cancer susceptibility gene and uses thereof
CA002238010A CA2238010A1 (en) 1995-11-23 1996-11-25 Materials and methods relating to the identification and sequencing of the brca2 cancer susceptibility gene and uses thereof
AU76350/96A AU707636C (en) 1995-11-23 1996-11-25 Materials and methods relating to the identification and sequencing of the BRCA2 cancer susceptibility gene and uses thereof
AT96939218T ATE259378T1 (en) 1995-11-23 1996-11-25 MATERIALS AND METHODS RELATED TO THE IDENTIFICATION AND SEQUENCING OF THE CANCER SUSCEPTILEITY GENE BRCA2 AND ITS APPLICATIONS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9523959.6A GB9523959D0 (en) 1995-11-23 1995-11-23 Materials and methods relating to the diagnosis and prophylactic and therapeutic treatment of cancer

Publications (1)

Publication Number Publication Date
GB9523959D0 true GB9523959D0 (en) 1996-01-24

Family

ID=10784336

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9523959.6A Pending GB9523959D0 (en) 1995-11-23 1995-11-23 Materials and methods relating to the diagnosis and prophylactic and therapeutic treatment of cancer

Country Status (1)

Country Link
GB (1) GB9523959D0 (en)

Similar Documents

Publication Publication Date Title
HUP9902068A3 (en) Methods and compositions for the diagnosis and treatment of cancer
EP0831904A4 (en) Treatment and diagnosis of prostate cancer
HU9602583D0 (en) Gel for treatment of skin diseases and for disinfection of the skin
EP0907369A4 (en) Materials and methods for treatment of plaquing diseases
GR980300033T1 (en) Compositions for the treatment of dermatological disorders and methods for their use
AU4473596A (en) Methods of human prostate cancer diagnosis
IL110464A0 (en) Novel proteins for the diagnosis, imaging, and therapy of human cancer
HUP9904317A3 (en) Use of 1-hydroxy-2-pyridones for producing pharmaceutical compositions suitable for the treatment of skin diseases
PL321741A1 (en) Bicyclic derivatives of isothiourea useful in medical therapy
AU2986595A (en) Materials and methods relating to the diagnosis and prophylactic and therapeutic treatment of synovial sarcoma
PL336760A1 (en) Treatment of skin diseases
IL116733A0 (en) The use of sertraline to treat cancer patients
AU7316196A (en) Diagnosis of susceptibility to cancer and treatment thereof
ZA969147B (en) Application of the gax protein to the treatment of cancer
HUP9800829A3 (en) Collagen-based methods and formulations for the treatment of immune system-mediated diseases
EP0733365A3 (en) Use of benzoquinolin-3-ones for the treatment and prevention of prostatic cancer
GB9523959D0 (en) Materials and methods relating to the diagnosis and prophylactic and therapeutic treatment of cancer
GB9525555D0 (en) Materials and methods relating to the diagnosis and prophylactic and therapeutic treatment of cancer
GB9617961D0 (en) Materials and methods relating to the diagnosis and prophylactic and therapeuti treatment of cancer
AU1413997A (en) Use of rc-9 in diagnosis and treatment of proliferative arterial disease
GB9523984D0 (en) Materials and methods relating to the diagnosis and prophylactic and therapeutic treatment of tuberculosis
GB9604985D0 (en) Materials and methods relating to the diagnosis of susceptibility to and the prophylactic and therapeutic treatment of certain diseases
HUP9800272A3 (en) Use of penciclovir for the treatment of human herpes-virus-8
ZA936136B (en) Treatment of skin diseases
GB9517072D0 (en) Dienes for use in the treatment of skin diseases and cancer